Q/C Technologies is a Nasdaq microcap that has now discarded two operating identities in a single year and is asking the market to underwrite a third. The company began the year as a former TNF-alpha drug developer that had licensed Israeli laser processors for cryptocurrency mining. By late June it had torn up that license, written the related intangible to zero, and declared that the residual franchise is a proprietary silicon photonic processor for artificial intelligence inference. The investment debate is not whether optical compute is an interesting research field. The debate is whether this particular issuer, after a one-for-one-hundred reverse split and a ticker change, has the people, the intellectual property, and the cash to build anything a customer would buy.
The June quarter made the cost of the reset visible. Product revenue stayed at zero, while the company recorded a license impairment of $3 million and stock-based compensation that dwarfed cash research spending. Cash in the bank fell to a few hundred thousand, with the real liquidity sitting in a marketable-securities book of about $11 million. That book is what funds the San Francisco lab and whatever engineering team the new chief technology officer can assemble. It is also what sits underneath a preferred stack whose stated liquidation claims are roughly the same size as the securities portfolio.
Two subsequent events reset the personnel story again. In mid September the company ended consulting arrangements with Chelsea Voss and with an affiliate of Martin Shkreli, and Voss left the board. Days later it named Yossef Ehrlichman, a silicon-photonics engineer with issued patents on micro-ring devices, as chief technology officer. The share price then traded through a sub-dollar print and a one-day volume spike that exceeded the entire float many times over. The question the next several quarters resolve is simple: does the optical program produce a staged hardware milestone before the securities portfolio and the Nasdaq bid-price test force another recapitalization?